神經元科技榮獲經濟部中小企業創新研究獎
很開心跟大家分享這個好消息：神經元科技旗下的NeuroSwift Pro智慧神經眼動診斷系統在今年度獲得經濟部中小企業創新研究獎的肯定。這項獎項主要表揚在研發深度、技術創新與產業影響力上具有代表性的中小企業。
NeuroSwift Pro將醫療級眼動追蹤技術與AI演算法整合，協助臨床評估多項神經功能，包括眼動控制、腦幹功能、動態視覺處理、注意力反應與神經可塑性等指標，並提升診斷流程的客觀化與效率。目前已陸續導入國際多家醫學中心與區域醫院使用，也在市場獲得醫療單位與合作夥伴的高度興趣。
感謝長期支持神經元的醫療夥伴、研究團隊與全球合作伙伴，未來我們將持續以眼動與AI為核心，開發更多可在臨床與社會真正創造價值的腦健康科技。
NeuroSwift Pro將醫療級眼動追蹤技術與AI演算法整合，協助臨床評估多項神經功能，包括眼動控制、腦幹功能、動態視覺處理、注意力反應與神經可塑性等指標，並提升診斷流程的客觀化與效率。目前已陸續導入國際多家醫學中心與區域醫院使用，也在市場獲得醫療單位與合作夥伴的高度興趣。
感謝長期支持神經元的醫療夥伴、研究團隊與全球合作伙伴，未來我們將持續以眼動與AI為核心，開發更多可在臨床與社會真正創造價值的腦健康科技。
Nov 24, 2025
Neurobit Partners with Recon Supply to Modernize Vestibular Diagnostics in VA and DoD Hospitals
AI-powered eye-tracking delivers faster, objective assessments to improve care for veterans
Neurobit Technologies (https://www.neurobittech.com/), an innovative medtech startup specializing in AI-powered eye-tracking and vestibular assessment, today announced a strategic partnership with Recon Supply (www.recon-supply.com/), a veteran-owned medical equipment distributor serving U.S. Department of Veterans Affairs (VA) and the Department of Defense (DoD) healthcare systems.
The partnership combines Neurobit’s intelligent neurological technology with Recon Supply’s federal-contracting expertise to bring faster, objective vestibular diagnostics into hospitals and clinics caring for veterans and active-duty personnel. Veterans frequently experience dizziness, balance disorders, and vertigo, often resulting from traumatic brain injuries (TBI), blast exposures, and age-related conditions. Data shows the disparity: 24.3% of male veterans report balance problems, compared to 18.7% of nonveteran men. Among veterans with TBI, 92% report imbalance and 53% report vertigo. Current diagnostic methods can be subjective, specialist-dependent, and time-consuming, with traditional tests taking up to an hour.
Neurobit’s flagship product, NeuroSwift™ Pro with AIVertigo, is an FDA Class II medical device that provides an integrated, AI-assisted eye-movement diagnostic solution, rapidly assess brain function, stratify risk, and streamline triage in 10 minutes or less. “It’s a major milestone to partner with Recon Supply”, said Travis Yang, Co-Founder and CEO of Neurobit Technologies, “ as this will accelerate clinical adoption and help modernize VA healthcare system with data-supported, time-saving and cost-effective solutions.”
As part of the collaboration, a pilot program will launch at selected VA hospitals, providing neurologists, ENT specialists and primary-care physicians to experience the real-world clinical impact.“Working with Neurobit aligns with our mission to deliver advanced, veteran-centric technologies across VA and DoD healthcare systems,” said Stephen Clark, Founder of Recon Supply. “As a veteran myself, I’m product to bring this innovative solution to care for my veteran peers, who care for our nation. Together, we can enhance both clinical accuracy and patient outcomes.”
About Neurobit
Neurobit Technologies develops advanced diagnostic systems that reveal brain and vestibular function through eye movement. Its products, including NeuroSwift, NeuroSwift Pro, and AIVertigo, are trusted by hospitals and research centers worldwide, providing reliable, real-time data to support early diagnosis, clinical decision-making, and patient monitoring.
About Recon Supply
Recon Supply is a veteran-owned medical device distributor that specifically provides equipment and solutions to U.S. federal healthcare agencies, including VA and DoD hospitals. The company connects emerging med-tech innovations with the needs of military and veteran healthcare providers.
Neurobit Technologies Contact:
Daphne Wang Stubbs
www.neuorbittech.com
Neurobit Technologies (https://www.neurobittech.com/), an innovative medtech startup specializing in AI-powered eye-tracking and vestibular assessment, today announced a strategic partnership with Recon Supply (www.recon-supply.com/), a veteran-owned medical equipment distributor serving U.S. Department of Veterans Affairs (VA) and the Department of Defense (DoD) healthcare systems.
The partnership combines Neurobit’s intelligent neurological technology with Recon Supply’s federal-contracting expertise to bring faster, objective vestibular diagnostics into hospitals and clinics caring for veterans and active-duty personnel. Veterans frequently experience dizziness, balance disorders, and vertigo, often resulting from traumatic brain injuries (TBI), blast exposures, and age-related conditions. Data shows the disparity: 24.3% of male veterans report balance problems, compared to 18.7% of nonveteran men. Among veterans with TBI, 92% report imbalance and 53% report vertigo. Current diagnostic methods can be subjective, specialist-dependent, and time-consuming, with traditional tests taking up to an hour.
Neurobit’s flagship product, NeuroSwift™ Pro with AIVertigo, is an FDA Class II medical device that provides an integrated, AI-assisted eye-movement diagnostic solution, rapidly assess brain function, stratify risk, and streamline triage in 10 minutes or less. “It’s a major milestone to partner with Recon Supply”, said Travis Yang, Co-Founder and CEO of Neurobit Technologies, “ as this will accelerate clinical adoption and help modernize VA healthcare system with data-supported, time-saving and cost-effective solutions.”
As part of the collaboration, a pilot program will launch at selected VA hospitals, providing neurologists, ENT specialists and primary-care physicians to experience the real-world clinical impact.“Working with Neurobit aligns with our mission to deliver advanced, veteran-centric technologies across VA and DoD healthcare systems,” said Stephen Clark, Founder of Recon Supply. “As a veteran myself, I’m product to bring this innovative solution to care for my veteran peers, who care for our nation. Together, we can enhance both clinical accuracy and patient outcomes.”
About Neurobit
Neurobit Technologies develops advanced diagnostic systems that reveal brain and vestibular function through eye movement. Its products, including NeuroSwift, NeuroSwift Pro, and AIVertigo, are trusted by hospitals and research centers worldwide, providing reliable, real-time data to support early diagnosis, clinical decision-making, and patient monitoring.
About Recon Supply
Recon Supply is a veteran-owned medical device distributor that specifically provides equipment and solutions to U.S. federal healthcare agencies, including VA and DoD hospitals. The company connects emerging med-tech innovations with the needs of military and veteran healthcare providers.
Neurobit Technologies Contact:
Daphne Wang Stubbs
www.neuorbittech.com
Oct 13, 2025
NeuroSwift Pro智慧神經眼動診斷系統榮獲「2025臺北生技獎」銀獎！
「生技產業奧斯卡」之稱的 2025臺北生技獎於日前舉行頒獎典禮，我們的 NeuroSwift Pro智慧神經眼動診斷系統榮獲創新技術獎（醫療器材組）銀獎 的殊榮！
NeuroSwift Pro專為中樞與周邊性眩暈鑑別、腦神經風險篩檢設計，結合高解析眼球運動追蹤與視覺誘發測試，可應用於神經內科、耳鼻喉科與健康檢查。系統內建AI自動分析模組，即時判讀眼動特徵並生成報告，協助醫師快速辨識腦幹、前庭與眼動功能異常。
未來，神經元將持續推動不同模組、遠距評估與多病症預警的開發，打造智慧神經診斷平台的新典範。
NeuroSwift Pro專為中樞與周邊性眩暈鑑別、腦神經風險篩檢設計，結合高解析眼球運動追蹤與視覺誘發測試，可應用於神經內科、耳鼻喉科與健康檢查。系統內建AI自動分析模組，即時判讀眼動特徵並生成報告，協助醫師快速辨識腦幹、前庭與眼動功能異常。
未來，神經元將持續推動不同模組、遠距評估與多病症預警的開發，打造智慧神經診斷平台的新典範。
Sep 30, 2025
2025 高齡健康產業博覽會｜腦健康快篩會後回顧
在今年的高齡健康產業博覽會中，我們運用NeuroSwift Pro針對136位21歲以上民眾進行腦健康快篩。透過這項活動，我們可初步了解成人腦健康的現況，並將檢測結果轉化為衛教資訊，協助民眾在早期就能察覺潛在腦功能異常，守護長期健康。
檢測結果顯示，低或正常風險族群占比92%，而高風險與中風險族群各占4%，換言之，約8%的受測者已出現潛在腦健康異常，這可能反映早期腦功能退化的訊號。值得注意的是，多數受測者自覺健康，但透過NeuroSwift Pro眼動與平衡測試，仍有部分族群存在早期異常風險。
這些檢測結果顯示，眼動與平衡功能其實反映了多個關鍵腦區的健康狀態。小腦負責動作協調與精準度，異常時可能出現步態不穩、手抖或眼球追蹤異常；腦幹則整合來自前庭系統（內耳平衡）、視覺與本體感覺的訊號，是維持姿勢與穩定的核心中樞；而基底核則與動作的啟動與控制密切相關，一旦受影響，可能會出現僵硬、顫抖或動作遲緩。這些腦區的功能障礙往往在記憶力衰退之前就會浮現，因此在臨床觀察中，許多神經退化疾病的早期徵兆，常先表現在平衡異常、眼球運動異常或步態變化上。藉由神經元的腦健康快篩，我們能在日常生活還未出現明顯症狀之前，便提早辨識腦健康風險，盡早介入並採取保養措施。
至於日常維護腦部健康，除了定期檢測之外，更需要從生活型態著手：規律的有氧運動與平衡訓練能活化神經連結；均衡飲食如攝取足夠的 Omega-3、抗氧化食物與多酚能降低腦部發炎；良好的睡眠則協助代謝清除腦內廢物；而持續學習、參與社交互動，則能保持神經網絡活躍。這些日常選擇雖然看似簡單，卻能在長期累積下有效延緩腦部退化，守護健康老化的關鍵基礎。
腦健康快篩不僅評估眼動與平衡，更是一種結合AI與眼球運動分析的早期腦功能監測工具。透過定期檢測與數據追蹤，我們能在症狀尚未出現前掌握自身腦健康狀態，提前採取保養行動，守護健康老化。
在本次 136 位受測者中，女性比例約占 79%，男性約 21%，顯示女性族群對腦健康檢測的參與度較高。年齡分布則以 61–70 歲最多（41%），其次為 51–60 歲（24%）與 41–50 歲（11%），而 21–40 歲及 71 歲以上族群則分別占 7% 與 17%。這樣的參與分布提醒我們，腦健康並不是專屬於老年的議題，而是每個世代都需要及早關注與持續經營的長期健康課題。
檢測結果顯示，低或正常風險族群占比92%，而高風險與中風險族群各占4%，換言之，約8%的受測者已出現潛在腦健康異常，這可能反映早期腦功能退化的訊號。值得注意的是，多數受測者自覺健康，但透過NeuroSwift Pro眼動與平衡測試，仍有部分族群存在早期異常風險。
這些檢測結果顯示，眼動與平衡功能其實反映了多個關鍵腦區的健康狀態。小腦負責動作協調與精準度，異常時可能出現步態不穩、手抖或眼球追蹤異常；腦幹則整合來自前庭系統（內耳平衡）、視覺與本體感覺的訊號，是維持姿勢與穩定的核心中樞；而基底核則與動作的啟動與控制密切相關，一旦受影響，可能會出現僵硬、顫抖或動作遲緩。這些腦區的功能障礙往往在記憶力衰退之前就會浮現，因此在臨床觀察中，許多神經退化疾病的早期徵兆，常先表現在平衡異常、眼球運動異常或步態變化上。藉由神經元的腦健康快篩，我們能在日常生活還未出現明顯症狀之前，便提早辨識腦健康風險，盡早介入並採取保養措施。
至於日常維護腦部健康，除了定期檢測之外，更需要從生活型態著手：規律的有氧運動與平衡訓練能活化神經連結；均衡飲食如攝取足夠的 Omega-3、抗氧化食物與多酚能降低腦部發炎；良好的睡眠則協助代謝清除腦內廢物；而持續學習、參與社交互動，則能保持神經網絡活躍。這些日常選擇雖然看似簡單，卻能在長期累積下有效延緩腦部退化，守護健康老化的關鍵基礎。
腦健康快篩不僅評估眼動與平衡，更是一種結合AI與眼球運動分析的早期腦功能監測工具。透過定期檢測與數據追蹤，我們能在症狀尚未出現前掌握自身腦健康狀態，提前採取保養行動，守護健康老化。
在本次 136 位受測者中，女性比例約占 79%，男性約 21%，顯示女性族群對腦健康檢測的參與度較高。年齡分布則以 61–70 歲最多（41%），其次為 51–60 歲（24%）與 41–50 歲（11%），而 21–40 歲及 71 歲以上族群則分別占 7% 與 17%。這樣的參與分布提醒我們，腦健康並不是專屬於老年的議題，而是每個世代都需要及早關注與持續經營的長期健康課題。
Sep 2, 2025
Taipei showcases cutting-edge medical devices & diagnostics at Medica 2024
Neurobit Technologies (Hall 16, E02-2), a company specializing in neurological disease screening, has developed a wearable eye-tracking device. Their NeuroSwift solution uses advanced algorithms to analyze eye movements and pupil responses, providing valuable diagnostic data for healthcare professionals.
Oct 22, 2024
ACTION: Neurobit participates in the 2023 Taiwan-Thailand Smart Healthcare Conference
"We are delighted to announce our participation in the "2023 Taiwan-Thailand Smart Healthcare Conference" hosted by Changhua Christian Hospital. This event provides a prestigious international platform for Taiwanese innovative medical device startups to showcase their cutting-edge biomedical technologies to over 250 medical professionals in the Taiwan-Thailand healthcare industry."
「很榮幸此次受邀參與彰基於曼谷主辦的「2023台泰智慧醫療研討會」，為台灣精準醫療的生醫新創打造一個國際舞台，向250多位台泰醫衛相關重量級人士展現台灣頂尖的生醫技術。」
「很榮幸此次受邀參與彰基於曼谷主辦的「2023台泰智慧醫療研討會」，為台灣精準醫療的生醫新創打造一個國際舞台，向250多位台泰醫衛相關重量級人士展現台灣頂尖的生醫技術。」
|
Sep 13, 2023
|
ARTICLE: 沉浸式醫療2／台灣起跑中！7大領域應用藏黑馬 產業鏈見端倪
「當醫療結合VR、AR、MR等技術，一個虛擬的人體就浮現在元宇宙的世界裡，器官、腫瘤、血管、神經，人體大小構造都鉅細靡遺，不僅有助於醫師進行手術模擬導航，還可應用在醫學教育、醫病衛教、復健治療、心理診斷治療、疾病篩檢、長照支援等領域。」
|
Sep 11, 2023
|
Neurobit Technologies Unveils FDA 510(k) Clearance for NeuroSwift Pro:
An Advanced Solution for Efficient Vestibular Disorder Identification
Aug 15, 2023
ARTICLE: Neurobit Unveils NeuroSwift at CES 2023
"Neurobit Technologies Co. Ltd showcased its latest wearable smart medical device solutions—NeuroSwift—at the recent Consumer Electronics Show (CES) 2023 in Las Vegas, Nevada."
Jan 16, 2023 |
ARTICLE: Fresh tech unveiled at CES
Jan 6, 2023 |
2022/12 Updates
Taipei, Taiwan – We are thrilled to announce that we have been named a CES® 2023 Innovation Awards Honoree for NeuroSwift. This year’s CES Innovation Awards program received a record high number of over 2100 submissions. The announcement was made ahead of CES 2023, the world’s most influential technology event, happening Jan. 5-8 in Las Vegas, NV.
|
The CES 2023 Innovation Awards HonoreesProduct descriptions and photos can be found at CES.tech/innovation. More will be revealed in January. Many honorees will showcase their winning products in the Innovation Awards Showcase at CES 2023.
|
NeuroSwift
NeuroSwift is an 100 percent in-house developed wearable smart medical device solution. It is designed to provide a complete solution for clinicians to identify patients with potential eye movement disorders and strabismus. The cameras inside the goggles will capture the eye movement of the patients, and the AI computer vision software will analyze the obtained data to generate analytic report. With the AI and machine learning software, NeuroSwift enables remote patient monitoring and consultation from any location with high quality videos and analytic reports, providing comprehensive communication.
About Neurobit
With the aim of providing revolutionary technology to the medical community, Neurobit integrated both hardware and software system from eye to brain which leverages artificial intelligence and machine learning for improved diagnostic precision that eases the lives of healthcare professionals around the globe. Our mission is to solve unmet neuro-clinical needs and offer a triple-win solution to professionals, patients and insurance companies.
Dec 31, 2022
ARTICLE: TTA首創智慧診療劇場 Showtime助智醫新創探商機
Nov 29, 2022 |
ARTICLE: MEDICA台廠大秀台灣高階醫材創新實力
Npv 18, 2022 |
ARTICLE: Glasses that can detect stroke by reading eye movements
Aug 24, 2022 |
ARTICLE: 【解決方案】神經元科技 動鑑觀顫 以眼為始 最佳智慧醫療輔助者
Aug 18, 2022 |
ARTICLE: 創意與技術俱佳 新創團隊注入台灣智慧醫療活水
「相較於市場上的眼震儀及量表評估，神經元科技的快篩設備具備操作簡易、可量化數據，且可定性定量判斷暈眩，因此技術一問世便吸引醫界眼光，目前該公司已與國內醫療機構合作進行臨床測驗，接下來將走出海外，將產品推廣至歐盟與美國市場。」
Dec 23, 2021 |
ARTICLE: AI眼鏡揪斜視 以動眼影像量化演算異常角度
「『智慧型眼鏡攝影套組』，能夠快速紀錄眼睛轉動的情況，提供客觀的斜視度數給醫師進行治療決策，同時穿戴方便，不需助手來協助拍照。」
Oct 12, 2021 |
ARTICLE: Medical AI startup Neurobit hits US$3.6 million valuation
"Medical artificial intelligence (AI) company Neurobit has announced its completion of angel round today, saying that since the seed round, the Taiwan-based startup has secured over US$1.1 million investment."
Aug 2, 2021 |
ARTICLE: D talk新創展現創意與技術 將腦中風機率與傷害降至最低
神經元科技，一「眼」看見中風徵兆
「成立於2016年的神經元科技，致力於提供兼具效率、實用且易用的穿戴式醫療智慧裝置及軟體服務，高風險腦部神經相關疾病快篩即是目前該團隊聚焦的領域。」
「成立於2016年的神經元科技，致力於提供兼具效率、實用且易用的穿戴式醫療智慧裝置及軟體服務，高風險腦部神經相關疾病快篩即是目前該團隊聚焦的領域。」
Oct 15, 2020 |
ARTICLE: 數位醫療新創神經元 解決醫療臨床痛點
今(11)日，由臺北市政府產業發展局主辦「2020臺北生技小聚」系列論壇，第二場次熱烈展開，以「步向2020數位醫療新十年」為主題，下半場邀請到神經元科技執行長楊鈞程以及醫守科技執行長龍安靖數位醫療新銳，與大家分享臺灣數位醫療於臨床上如何落地運用。
神經元科技執行長楊鈞程則為大家針對數位診斷醫療應用作分析，他表示，數位醫療市場規模蓬勃發展，北美市場佔46.2 %為佔比最高。從數位醫療生態系中，可發現大多是「以病患為中心」來發展，因此讓患者獲得更好的生活品質、更有幫助的個人健康管理系統是數位醫療的發展核心。
他指出，目前數位醫療法規比較完整的尚為歐美兩地，美國的數位健康創新計畫針對醫療軟體發布指引，也建立了CDRH數位健康部門，希望在FDA中建立審核監督能力；歐洲則建立2012-2020年數位醫療行動計畫，可以達到數據存取與共享安全性，並針對健康跟護理的數位醫療作完整規範。
在2020年第一季投資領域熱區分析中，因為疫情關係，也發現資金轉移到遠距醫療、病程監控、心理健康投資等。
神經元科技團隊觀察到眩暈誤診率高的臨床痛點，2016年9月成立了神經元科技，他指出，CT針對後顱型的腦出血、腦阻塞等急性中風敏感度低，神經元科技運用眼球震顫學及大數據演算法，開發出名為Neurospeed的智慧眼鏡，架構於名為 HINTS 的臨床神經檢查法，可透過特定狀況的眼球運動觀察出周邊性神病病因或中樞性神經病因，協助快速判斷出急性腦中風患者。
楊鈞程認為，健康管理、生活習慣管理、基因分析等數位健康領域都是未來發展機會，穿戴式醫療器材中，通過FDA認證將會是未來趨勢，而在臺灣，醫療與工程人才是兩大枝幹，ICT跟醫療健保數據庫的優勢，是臺灣未來數位醫療發展的利基。
神經元科技執行長楊鈞程則為大家針對數位診斷醫療應用作分析，他表示，數位醫療市場規模蓬勃發展，北美市場佔46.2 %為佔比最高。從數位醫療生態系中，可發現大多是「以病患為中心」來發展，因此讓患者獲得更好的生活品質、更有幫助的個人健康管理系統是數位醫療的發展核心。
他指出，目前數位醫療法規比較完整的尚為歐美兩地，美國的數位健康創新計畫針對醫療軟體發布指引，也建立了CDRH數位健康部門，希望在FDA中建立審核監督能力；歐洲則建立2012-2020年數位醫療行動計畫，可以達到數據存取與共享安全性，並針對健康跟護理的數位醫療作完整規範。
在2020年第一季投資領域熱區分析中，因為疫情關係，也發現資金轉移到遠距醫療、病程監控、心理健康投資等。
神經元科技團隊觀察到眩暈誤診率高的臨床痛點，2016年9月成立了神經元科技，他指出，CT針對後顱型的腦出血、腦阻塞等急性中風敏感度低，神經元科技運用眼球震顫學及大數據演算法，開發出名為Neurospeed的智慧眼鏡，架構於名為 HINTS 的臨床神經檢查法，可透過特定狀況的眼球運動觀察出周邊性神病病因或中樞性神經病因，協助快速判斷出急性腦中風患者。
楊鈞程認為，健康管理、生活習慣管理、基因分析等數位健康領域都是未來發展機會，穿戴式醫療器材中，通過FDA認證將會是未來趨勢，而在臺灣，醫療與工程人才是兩大枝幹，ICT跟醫療健保數據庫的優勢，是臺灣未來數位醫療發展的利基。
Aug 11, 2020 |
ACTION: Neurobit From Taiwan Won WESCALE Health Challenge Pitching Prize In Utrecht
Sep 30, 2019 |
VIDEO: Neurobit's Interview on Bloomberg
We're glad to have the chance to be interviewed by Bloomberg within vast and various exhibitors.
Aug 19, 2019 |
VIDEO: Neurobit @ Innovfest Unbound 2019
We're welcomed by organizations as SingHealth, Changi General Hospital Innovation Center, and we met large corporations like Cisco, MetLife, Huawei, and multiple VCs.
Thanks for Taiwan Tech Arena and NUS Enterprise.
Watch our report through local media from USTV in Taiwan.
Thanks for Taiwan Tech Arena and NUS Enterprise.
Watch our report through local media from USTV in Taiwan.
Jun 27, 2019
ARTICLE: 微軟DevDays Asia 2019亞太技術年會開跑！盼透過跨界整合極大化雲端使用加速產業創新
「來自台灣的智慧醫材公司Neurobit Technologies神經元科技，推出可紀錄眼球震顫的智能眼鏡。」
May 21, 2019 |
ACTION: Neurobit joins the Microsoft for Startups
「台灣微軟昨（22）日宣布『微軟新創加速器』台北第一期新創團隊獲選的 14 支隊伍名單...」
Apr 23, 2019 |
ARTICLE: 台灣mini獨角獸現身
「沒有富爸爸的加持，只能靠自己主動出擊。從台港澳到美國西部矽谷參加創業英雄營，再到東岸的波士頓，都有執行長楊鈞程的足跡，就是不想錯失任何國際資源的鏈結。『不是要打假球，而是真的要幹下去。』他表示。」
⠀Mar 13, 2019 |
ARTICLE: 眼球震顫的唯一先驅，快篩潛在中風患者掌握黃金治療時間
「其實九成的腦中風能透過危管理險因子而有效預防，若能快速辨識腦中風症狀並即時就醫，可大為降低死亡與失能的風險。」
Feb 19, 2019 |
ARTICLE: Neurobit launches nystagmus-recording smart glasses
"Neurobit Technologies has developed wireless smart glasses that can record nystagmus waveforms and analyze related imaging data to make early prediction and prevention of strokes and other brain diseases..."
Jan 28, 2019 |
ACTION: Neurobit at the 2018 Microsoft IoT in Action
⠀12/13/2018
ACTION: Neurobit wins the Most Investible Award from Silicon Valley Draper University - Fall 2018
Oct 17, 2018 |
SPEECH: 眼球震顫與腦中風的秘密 | 黃勁勛 Jim Huang | TEDxTaipei
Sep 30, 2018
ARTICLE: 檢查「眼睛」就知道有沒有中風！Neurobit 要成為眼球震顫領域的先驅
「腦中風高居全球第二大死因，而中風往往來得出其不意，黃金治療時間僅約三小時，許多患者因延誤就醫喪失搶救先機。除了事後搶救，醫學上又有什麼方法可以事先預防呢？」
Jun 15, 2018 |
